BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 29, 2016
View Archived Issues
NIAID grant supports Navigen's development of depot formulation for treatment and prevention of HIV
Read More
Bristol Myers Squibb synthesizes potent and selective FXIa inhibitors
Read More
Phase III trial of BioChaperone PDGF for diabetic foot ulcer does not meet the primary endpoint
Read More
FDA issues EUA for Roche PCR Zika test, updates blood donation screening guidance
Read More
Xeloda approved for additional indication of adjuvant chemotherapy for rectal cancer
Read More
Cardiac biomarker responses seen with NEOD-001 in AL amyloidosis patients
Read More
Japanese orphan drug designation awarded to emicizumab in hemophilia A
Read More
F-star and Denali enter collaborative agreement to develop a multispecific antibody platform
Read More
AM-0466 described as a potent and selective Nav1.7 inhibitor with analgesic efficacy in vivo
Read More
Treakisym approved in Japan for the additional indication of chronic lymphocytic leukemia
Read More
Valixa approved in Japan for CMV prevention in organ transplant patients
Read More
Bristol Myers Squibb identifies BMS-212 as potent, liver-selective GK activator
Read More
Cell Medica collaborates with UCL on modified TCR products for the treatment of cancer
Read More
Enzymes in the kynurenine pathway linked to suicide risk
Read More
Ferring signs licensing agreement with Seikagaku for condoliase
Read More
Arog initiates phase III trial of crenolanib for advanced GIST
Read More
Bristol-Myers Squibb initiates phase I trial of BMS-986195
Read More
Piramal Enterprises discloses GPR120 agonists
Read More
FDA grants orphan drug designation to Gilead's ambrisentan/tadalafil combination
Read More
Sage Therapeutics patents GABA (A) receptor modulators
Read More
Japanese approval sought for Vimpat monotherapy for partial onset seizures
Read More
Ginkgo Pharmaceutical describes novel nucleoside derivatives
Read More
Sorrento Therapeutics discloses anti-HER2 antibody-dolastatin derivative conjugates
Read More
Spotlight Innovation enters sponsored research agreement with FSU to treat Zika infection
Read More
Trillium Therapeutics discovers bromodomain-containing protein inhibitors
Read More
BARDA awards USD 5.3 million to SAB Biotherapeutics for MERS treatment testing
Read More